-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 JwE6lpegGx3CHaAG0+8xEE0t15s6Bh1b/YkKL4sJ1yU6FHgeu5PrVVwCTs7dTxEs
 hrBz8OT91L8ItEE6wElYmQ==

<SEC-DOCUMENT>0000943440-06-000383.txt : 20061108
<SEC-HEADER>0000943440-06-000383.hdr.sgml : 20061108
<ACCEPTANCE-DATETIME>20061108124435
ACCESSION NUMBER:		0000943440-06-000383
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20061108
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20061108
DATE AS OF CHANGE:		20061108

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PETMED EXPRESS INC
		CENTRAL INDEX KEY:			0001040130
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				650680967
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			0330

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-28827
		FILM NUMBER:		061196386

	BUSINESS ADDRESS:	
		STREET 1:		1441 SW 29 AVENUE
		CITY:			POMPANO BEACH
		STATE:			FL
		ZIP:			33069
		BUSINESS PHONE:		9549794788

	MAIL ADDRESS:	
		STREET 1:		1441 SW 29 AVENUE
		CITY:			POMPANO BEACH
		STATE:			FL
		ZIP:			33069
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k-nov8.txt
<TEXT>

                          UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                      Washington, DC 20549

                            FORM 8-K

                         CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)  November 8, 2006
                                                 ------------------
                      PETMED EXPRESS, INC.
     -------------------------------------------------------
     (Exact name of registrant as specified in its charter)

          Florida                000-28827       65-0680967
- ------------------------------------------------------------------
(State or other jurisdiction   (Commission      (IRS Employer
     of incorporation)         File Number)   Identification No.)

   1441 S.W. 29th Avenue, Pompano Beach, Florida      33069
- ------------------------------------------------------------------
    (Address of principal executive offices)        (Zip Code)

Registrant's telephone number, including area code  (954) 979-5995
                                                   ----------------

  -------------------------------------------------------------
  (Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):

     [  ]  Written communications pursuant to Rule 425 under the
           Securities Act (17 CFR 230.425)

     [  ]  Soliciting material pursuant to Rule 14a-12 under the
           Exchange Act (17 CFR 240.14a-12)

     [  ]  Pre-commencement communications pursuant to Rule 14d-
           2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     [  ]  Pre-commencement communications pursuant to Rule 13e-
           4(c) under the Exchange Act (17 CFR 240.13e-4(c))


<PAGE>


Item 7.01 Regulation FD Disclosure

Item 8.01 Other Events

      On  November 8, 2006, PetMed Express, Inc. issued  a  press
release announcing that the Board of Directors of PetMed Express,
Inc.  has  approved  a  share repurchase program  of  up  to  $20
million, effective immediately.  This program is intended  to  be
implemented  through purchases made from time to time  in  either
the  open market or through private transactions at the Company's
discretion,  subject to market conditions and other  factors,  in
accordance  with Securities and Exchange Commission requirements.
There  can  be no assurances as to the precise number  of  shares
that will be repurchased under the share repurchase program,  and
the  Company may discontinue the share repurchase program at  any
time   subject   to   compliance   with   applicable   regulatory
requirements.  Shares purchased pursuant to the share  repurchase
program  will  either  be  cancelled or  held  in  the  Company's
treasury.   A  copy  of the press release is attached  hereto  as
Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

     (c)  Exhibits

          99.1 Press release issued by PetMed Express, Inc. on
               November 8, 2006


                           SIGNATURES

     Pursuant to the requirements of the Securities Exchange  Act
of  1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.

                                 PETMED EXPRESS, INC.

Date:  November 8, 2006          By:/s/ Menderes Akdag
                                    -----------------------------
                                    Menderes Akdag,
                                    Chief Executive Officer and President

                                 By:/s/ Bruce S. Rosenbloom
                                    ------------------------------
                                    Bruce S. Rosenbloom,
                                    Chief Financial Officer








<PAGE>




                          EXHIBIT INDEX

Exhibit No.                Description


99.1 Press release issued by PetMed Express, Inc. on November 8, 2006

















<PAGE>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>form8k-nov8ex991.txt
<TEXT>

                          EXHIBIT 99.1

PETMED  EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES $20  MILLION  SHARE
REPURCHASE PROGRAM

Pompano Beach, Florida, November 8, 2006 - The Board of Directors
of  PetMed  Express,  Inc. (NASDAQ:PETS)  has  approved  a  share
repurchase  program of up to $20 million, effective  immediately.
This program is intended to be implemented through purchases made
from  time  to time in either the open market or through  private
transactions  at  the  Company's discretion,  subject  to  market
conditions  and other factors, in accordance with Securities  and
Exchange Commission requirements.  As of November 8, 2006, PetMed
Express, Inc. has 24.2 million shares outstanding.

"The  authorization  from the Board to repurchase  shares  is  an
indication  of our Company's financial strength and  demonstrates
the confidence we have in our Company," commented Menderes Akdag,
CEO and President of PetMed Express, Inc.  "The cash productivity
of our business model enables us to actively invest cash in areas
that  we believe will drive future value for shareholders.   This
share  repurchase plan demonstrates our continued  commitment  to
deliver long-term shareholder value."

Founded  in  1996,  PetMed  Express  is  America's  Largest   Pet
Pharmacy,   delivering  prescription  and  non-prescription   pet
medications and other health products for dogs, cats, and  horses
at  competitive prices direct to the consumer through its  1-800-
PetMeds  toll free number and on the Internet through its website
at www.1800petmeds.com.
   -------------------

This  press release may contain "forward-looking" statements,  as
defined  in the Private Securities Litigation Reform Act of  1995
or  by  the  Securities and Exchange Commission, that  involve  a
number  of  risks  and  uncertainties,  including  the  Company's
ability  to  meet the objectives included in its  business  plan.
Important  factors that could cause results to differ  materially
from those indicated by such "forward-looking" statements are set
forth  in  Management's  Discussion  and  Analysis  of  Financial
Condition  and Results of Operation in the PetMed Express  Annual
Report  on  Form  10-K for the year ended March  31,  2006.   The
Company's  future  results may also be  impacted  by  other  risk
factors  listed from time to time in its SEC filings,  including,
but not limited to, the Company's Form 10-Q and its Annual Report
on Form 10-K.

For  investment relations contact PetMed Express, Inc., Bruce  S.
Rosenbloom, CFO, 954-979-5995.

                               ###
                     Exhibit 99.1 Page 1 - 1

<PAGE>


</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
